Tardive Dyskinesia Treatment Market Report 2026
Download Free Sample Buy Now
Tardive Dyskinesia Treatment Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Tardive Dyskinesia Treatment Market Report 2026

Global Outlook – By Treatment Type (Medications, Botulinum Toxin Injections, Deep Brain Stimulation, Other Treatment Types), By Drug (Valbenazine, Amantadine, Tetrabenazine, Clonazepam, Other Drugs), By Route Of Administration (Oral Administration, Injection, Transdermal Patches), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By End-Users (Hospitals, Specialty Clinics, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Tardive Dyskinesia Treatment Market Overview

• Tardive Dyskinesia Treatment market size has reached to $2.61 billion in 2025

• Expected to grow to $3.9 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%

• Growth Driver: The Rise In Psychiatric Disorders Driving The Growth Of The Market Due To Increasing Mental Health Burden

• Market Trend: Innovative Drug Formulations Aim To Improve Care For Patients With Swallowing Difficulties

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Tardive Dyskinesia Treatment Market?

Tardive dyskinesia treatment refers to the medical management and therapeutic interventions aimed at reducing or controlling the involuntary, repetitive movements caused by long-term use of dopamine receptor-blocking agents, especially antipsychotics.

The main treatment types of tardive dyskinesia are medications, botulinum toxin injections, deep brain stimulation, and other treatment types. Medications refer to drugs specifically used to manage and reduce the involuntary, repetitive movements caused by long-term use of antipsychotic medications. Commonly used drugs are valbenazine, amantadine, tetrabenazine, clonazepam, and others. These treatments are administered through various routes, including oral administration, injection, and transdermal patches. These various distribution channels are hospital pharmacies, retail pharmacies, and others, and cater to various end users, including hospitals, specialty clinics, and others.

Tardive Dyskinesia Treatment Market Global Report 2026 Market Report bar graph

What Is The Tardive Dyskinesia Treatment Market Size and Share 2026?

The tardive dyskinesia treatment market size has grown strongly in recent years. It will grow from $2.61 billion in 2025 to $2.84 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to prolonged use of antipsychotic medications, increasing awareness of tardive dyskinesia, limited availability of specialized treatment options, rising mental health disorder prevalence, growing hospital neurology departments.

What Is The Tardive Dyskinesia Treatment Market Growth Forecast?

The tardive dyskinesia treatment market size is expected to see strong growth in the next few years. It will grow to $3.9 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to development of novel dopamine-depleting therapies, expansion of deep brain stimulation adoption, increasing botulinum toxin applications, integration of telemedicine for movement disorder management, rising investment in patient-specific rehabilitation and cognitive therapies. Major trends in the forecast period include increasing adoption of dopamine-depleting agents and anticholinergic medications, rising preference for botulinum toxin injections for focal dyskinesia, growth in use of deep brain stimulation for refractory tardive dyskinesia, expansion of customized injection protocols and multi-target dbs approaches, integration of cognitive behavioral therapy and supportive rehabilitation programs.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Tardive Dyskinesia Treatment Market Segmentation

1) By Treatment Type: Medications, Botulinum Toxin Injections, Deep Brain Stimulation, Other Treatment Types

2) By Drug: Valbenazine, Amantadine, Tetrabenazine, Clonazepam, Other Drugs

3) By Route Of Administration: Oral Administration, Injection, Transdermal Patches

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Medications: Antipsychotic Medications, Benzodiazepines, Dopamine-Depleting Agents, Anticholinergic Agents

2) By Botulinum Toxin Injections: Facial Muscle Injections, Neck Muscle Injections, Limb Muscle Injections, Customized Injection Protocols

3) By Deep Brain Stimulation: Subthalamic Nucleus Stimulation, Globus Pallidus Interna Stimulation, Thalamic Stimulation, Multi-Target Stimulation

4) By Other Treatment Types: Supportive Therapies, Cognitive Behavioral Therapy, Physical Rehabilitation, Emerging Experimental Treatments

What Is The Driver Of The Tardive Dyskinesia Treatment Market?

The increasing prevalence of psychiatric disorders is expected to propel the growth of the tardive dyskinesia treatment market going forward. Psychiatric disorders refer to a wide range of mental health conditions that affect a person's mood, thinking, behavior, and overall functioning, often requiring clinical diagnosis and treatment. The prevalence of psychiatric disorders is growing due to rising stress and lifestyle pressures resulting from high workloads, social isolation, and limited time for self-care. Tardive dyskinesia treatment helps manage involuntary movement symptoms, improving overall treatment outcomes and quality of life for individuals with psychiatric disorders who require long-term antipsychotic medication. For instance, in November 2023, according to the NHS England, a UK-based government health agency, about 20.3 % of children aged 8 to 16, 23.3 % of those aged 17 to 19, and 21.7 % of those aged 20 to 25 had a probable mental disorder in 2023. Therefore, the increasing prevalence of psychiatric disorders is driving the growth of the tardive dyskinesia treatment industry.

Key Players In The Global Tardive Dyskinesia Treatment Market

Major companies operating in the tardive dyskinesia treatment market are AbbVie Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Jazz Pharmaceuticals plc, Kyowa Kirin Co Ltd., H. Lundbeck A/S, Neurocrine Biosciences Inc., Acadia Pharmaceuticals Inc., Upsher-Smith Laboratories LLC, Adamas Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation.

Global Tardive Dyskinesia Treatment Market Trends and Insights

Major companies operating in the tardive dyskinesia treatment market are focusing on developing innovative drugs, such as sprinkle capsule formulations, to improve medication adherence for patients with swallowing difficulties. Sprinkle capsule formulations are medications designed to be opened and sprinkled onto soft food, making them easier to swallow for patients with dysphagia or difficulty taking whole capsules. For instance, in July 2024, Neurocrine Biosciences Inc., a US-based biotechnology company, launched Ingrezza sprinkle (valbenazine) capsules, the leading prescribed vesicular monoamine transporter 2 (VMAT2) inhibitor for treating adults with tardive dyskinesia and chorea associated with Huntington's disease. This VMAT2 inhibitor works by regulating dopamine levels in the brain to help manage involuntary movements. The medication is available as a once-daily oral capsule, including a sprinkle formulation designed to ease administration for patients who have difficulty swallowing.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Tardive Dyskinesia Treatment Market?

In April 2025, Johnson & Johnson, a US-based pharmaceutical industry company, acquired Intra-Cellular Therapies for an undisclosed amount. With this acquisition, Johnson & Johnson aims to strengthen its leadership in neuroscience and expand its presence in the fast-growing mental health treatment market. Intra-Cellular Therapies Inc. is a US-based pharmaceutical company that specializes in providing treatments for tardive dyskinesia.

Regional Insights

North America was the largest region in the tardive dyskinesia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Tardive Dyskinesia Treatment Market?

The tardive dyskinesia treatment market includes revenues earned by entities through botulinum toxin injection services, deep brain stimulation procedures, and diagnostic and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Tardive Dyskinesia Treatment Market Report 2026?

The tardive dyskinesia treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tardive dyskinesia treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Tardive Dyskinesia Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.84 billion
Revenue Forecast In 2035 $3.9 billion
Growth Rate CAGR of 8.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment Type, Drug, Route Of Administration, Distribution Channel, End-Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled AbbVie Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Jazz Pharmaceuticals plc, Kyowa Kirin Co Ltd., H. Lundbeck A/S, Neurocrine Biosciences Inc., Acadia Pharmaceuticals Inc., Upsher-S
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Tardive Dyskinesia Treatment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Tardive Dyskinesia Treatment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Tardive Dyskinesia Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Tardive Dyskinesia Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Dopamine-Depleting Agents And Anticholinergic Medications

4.2.2 Rising Preference For Botulinum Toxin Injections For Focal Dyskinesia

4.2.3 Growth In Use Of Deep Brain Stimulation For Refractory Tardive Dyskinesia

4.2.4 Expansion Of Customized Injection Protocols And Multi-Target DBS Approaches

4.2.5 Integration Of Cognitive Behavioral Therapy And Supportive Rehabilitation Programs

5. Tardive Dyskinesia Treatment Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Neurology Centers

5.4 Rehabilitation Centers

5.5 Research & Diagnostic Centers

6. Tardive Dyskinesia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tardive Dyskinesia Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Tardive Dyskinesia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Tardive Dyskinesia Treatment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Tardive Dyskinesia Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Tardive Dyskinesia Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tardive Dyskinesia Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tardive Dyskinesia Treatment Market Segmentation

9.1. Global Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medications, Botulinum Toxin Injections, Deep Brain Stimulation, Other Treatment Types

9.2. Global Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Valbenazine, Amantadine, Tetrabenazine, Clonazepam, Other Drugs

9.3. Global Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Administration, Injection, Transdermal Patches

9.4. Global Tardive Dyskinesia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

9.5. Global Tardive Dyskinesia Treatment Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Other End-Users

9.6. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antipsychotic Medications, Benzodiazepines, Dopamine-Depleting Agents, Anticholinergic Agents

9.7. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Botulinum Toxin Injections, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Facial Muscle Injections, Neck Muscle Injections, Limb Muscle Injections, Customized Injection Protocols

9.8. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Deep Brain Stimulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Subthalamic Nucleus Stimulation, Globus Pallidus Interna Stimulation, Thalamic Stimulation, Multi-Target Stimulation

9.9. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Supportive Therapies, Cognitive Behavioral Therapy, Physical Rehabilitation, Emerging Experimental Treatments

10. Tardive Dyskinesia Treatment Market Regional And Country Analysis

10.1. Global Tardive Dyskinesia Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Tardive Dyskinesia Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tardive Dyskinesia Treatment Market

11.1. Asia-Pacific Tardive Dyskinesia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tardive Dyskinesia Treatment Market

12.1. China Tardive Dyskinesia Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tardive Dyskinesia Treatment Market

13.1. India Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tardive Dyskinesia Treatment Market

14.1. Japan Tardive Dyskinesia Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tardive Dyskinesia Treatment Market

15.1. Australia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tardive Dyskinesia Treatment Market

16.1. Indonesia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tardive Dyskinesia Treatment Market

17.1. South Korea Tardive Dyskinesia Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tardive Dyskinesia Treatment Market

18.1. Taiwan Tardive Dyskinesia Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tardive Dyskinesia Treatment Market

19.1. South East Asia Tardive Dyskinesia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tardive Dyskinesia Treatment Market

20.1. Western Europe Tardive Dyskinesia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tardive Dyskinesia Treatment Market

21.1. UK Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tardive Dyskinesia Treatment Market

22.1. Germany Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tardive Dyskinesia Treatment Market

23.1. France Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tardive Dyskinesia Treatment Market

24.1. Italy Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tardive Dyskinesia Treatment Market

25.1. Spain Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tardive Dyskinesia Treatment Market

26.1. Eastern Europe Tardive Dyskinesia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tardive Dyskinesia Treatment Market

27.1. Russia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tardive Dyskinesia Treatment Market

28.1. North America Tardive Dyskinesia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tardive Dyskinesia Treatment Market

29.1. USA Tardive Dyskinesia Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tardive Dyskinesia Treatment Market

30.1. Canada Tardive Dyskinesia Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tardive Dyskinesia Treatment Market

31.1. South America Tardive Dyskinesia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tardive Dyskinesia Treatment Market

32.1. Brazil Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tardive Dyskinesia Treatment Market

33.1. Middle East Tardive Dyskinesia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tardive Dyskinesia Treatment Market

34.1. Africa Tardive Dyskinesia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tardive Dyskinesia Treatment Market Regulatory and Investment Landscape

36. Tardive Dyskinesia Treatment Market Competitive Landscape And Company Profiles

36.1. Tardive Dyskinesia Treatment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Tardive Dyskinesia Treatment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Tardive Dyskinesia Treatment Market Company Profiles

36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Jazz Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis

37. Tardive Dyskinesia Treatment Market Other Major And Innovative Companies

Kyowa Kirin Co Ltd., H. Lundbeck A/S, Neurocrine Biosciences Inc., Acadia Pharmaceuticals Inc., Upsher-Smith Laboratories LLC, Adamas Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation

38. Global Tardive Dyskinesia Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tardive Dyskinesia Treatment Market

40. Tardive Dyskinesia Treatment Market High Potential Countries, Segments and Strategies

40.1 Tardive Dyskinesia Treatment Market In 2030 - Countries Offering Most New Opportunities

40.2 Tardive Dyskinesia Treatment Market In 2030 - Segments Offering Most New Opportunities

40.3 Tardive Dyskinesia Treatment Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Tardive Dyskinesia Treatment Market, Overview Of Key Products - Product Examples
  • Table 2: Global Tardive Dyskinesia Treatment Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Tardive Dyskinesia Treatment Market, Supply Chain Analysis
  • Table 4: Global Tardive Dyskinesia Treatment Market, Major Raw Material Providers
  • Table 5: Global Tardive Dyskinesia Treatment Market, Major Resource Providers
  • Table 6: Global Tardive Dyskinesia Treatment Market, Major Manufacturers (Suppliers)
  • Table 7: Global Tardive Dyskinesia Treatment Market, Major Distributors And Channel Partners
  • Table 8: Global Tardive Dyskinesia Treatment Market, Key Technologies & Future Trends
  • Table 9: Global Tardive Dyskinesia Treatment Market, Major Trends
  • Table 10: Global Tardive Dyskinesia Treatment Market, Major End Users
  • Table 11: Global Tardive Dyskinesia Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Tardive Dyskinesia Treatment Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Tardive Dyskinesia Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Tardive Dyskinesia Treatment Market - TAM, US$ Billion, 2025
  • Table 15: Global Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Tardive Dyskinesia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Tardive Dyskinesia Treatment Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Botulinum Toxin Injections, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Deep Brain Stimulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Tardive Dyskinesia Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Tardive Dyskinesia Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Tardive Dyskinesia Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Tardive Dyskinesia Treatment Market - Company Scoring Matrix
  • Table 100: AbbVie Inc. Financial Performance
  • Table 101: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 102: Teva Pharmaceutical Industries Limited Financial Performance
  • Table 103: Otsuka Pharmaceutical Co. Ltd. Financial Performance
  • Table 104: Jazz Pharmaceuticals plc Financial Performance
  • Table 105: Global Tardive Dyskinesia Treatment Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Tardive Dyskinesia Treatment Market, Competitive Dashboard
  • Table 107: Global Tardive Dyskinesia Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Tardive Dyskinesia Treatment Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Table 109: Global, Tardive Dyskinesia Treatment Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030
  • Table 110: Global, Tardive Dyskinesia Treatment Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Tardive Dyskinesia Treatment Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Tardive Dyskinesia Treatment Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Tardive Dyskinesia Treatment Market, Supply Chain Analysis
  • Figure 4: Global Tardive Dyskinesia Treatment Market, Major Raw Material Providers
  • Figure 5: Global Tardive Dyskinesia Treatment Market, Major Resource Providers
  • Figure 6: Global Tardive Dyskinesia Treatment Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Tardive Dyskinesia Treatment Market, Major Distributors And Channel Partners
  • Figure 8: Global Tardive Dyskinesia Treatment Market, Key Technologies & Future Trends
  • Figure 9: Global Tardive Dyskinesia Treatment Market, Major Trends
  • Figure 10: Global Tardive Dyskinesia Treatment Market, Major End Users
  • Figure 11: Global Tardive Dyskinesia Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Tardive Dyskinesia Treatment Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Tardive Dyskinesia Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Tardive Dyskinesia Treatment Market - TAM, US$ Billion, 2025
  • Figure 15: Global Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Tardive Dyskinesia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Tardive Dyskinesia Treatment Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Botulinum Toxin Injections, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Deep Brain Stimulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Tardive Dyskinesia Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Tardive Dyskinesia Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Tardive Dyskinesia Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Tardive Dyskinesia Treatment Market - Company Scoring Matrix
  • Figure 100: AbbVie Inc. Financial Performance
  • Figure 101: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 102: Teva Pharmaceutical Industries Limited Financial Performance
  • Figure 103: Otsuka Pharmaceutical Co. Ltd. Financial Performance
  • Figure 104: Jazz Pharmaceuticals plc Financial Performance
  • Figure 105: Global Tardive Dyskinesia Treatment Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Tardive Dyskinesia Treatment Market, Competitive Dashboard
  • Figure 107: Global Tardive Dyskinesia Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Tardive Dyskinesia Treatment Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Figure 109: Global, Tardive Dyskinesia Treatment Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030
  • Figure 110: Global, Tardive Dyskinesia Treatment Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Tax Preparation Services Market Report 2026 - Global Outlook – By Service (Tax Compilation Services, Tax Return Preparation Services, Other Services), By Deployment Mode (Cloud, On-Premises), By Application (Enterprise, ...

Tax Management Software Market Report 2026 - Global Outlook – By Component (Software, Professional Services), By Tax Type (Direct Taxes, Indirect Taxes), By Deployment Mode (On-Premises, Cloud) – Market Size, Trends, Str...

Tax Management Market Report 2026 - Global Outlook – By Type (Software, Services), By Deployment Mode (Cloud, On-Premises), By Organization Size (Small and Medium-Sized Enterprises (SMES), Large Enterprises), By Applicat...

Pet Tech Market Report 2026 - Global Outlook – By Type (Radio Frequency Identification (RFID), Global Positioning System (GPS), Sensors, Other Types), By Distribution Channel (Offline, Online), By Application (Identifica...

Information Technology Market Report 2026 - Global Outlook – By Type (IT Services, Computer Hardware, Telecom, Software Products), By Organization Size (Large Enterprise, Small and Medium Enterprise), By End User (Financ...

Legal Technology Market Report 2026 - Global Outlook – By Type (Case Management, Lead Management, Document Management, Billing And Accounting), By Solution (E-Discovery, Legal Research, Legal Analytics, Document Manageme...

Space Technology (SpaceTech) Market Report 2026 - Global Outlook – By Type (Space Vehicles, Spacecraft, Space Stations, Orbital Launch Vehicles, Deep-Space Communications, In-Space Propulsion, Other Types), By Applicatio...

Revenue Assurance Market Report 2026 - Global Outlook – By Component (Software, Services), By Deployment Mode (Cloud, On-Premises), By Organization Size (Large Organizations, Small And Medium-Sized Enterprises (SMEs)), B...

Frequently Asked Questions

The Tardive Dyskinesia Treatment market was valued at $2.61 billion in 2025, increased to $2.84 billion in 2026, and is projected to reach $3.9 billion by 2030.

The global Tardive Dyskinesia Treatment market is expected to grow at a CAGR of 8.3% from 2026 to 2035 to reach $3.9 billion by 2035.

Some Key Players in the Tardive Dyskinesia Treatment market Include, AbbVie Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Jazz Pharmaceuticals plc, Kyowa Kirin Co Ltd., H. Lundbeck A/S, Neurocrine Biosciences Inc., Acadia Pharmaceuticals Inc., Upsher-Smith Laboratories LLC, Adamas Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation. .

Major trend in this market includes: Innovative Drug Formulations Aim To Improve Care For Patients With Swallowing Difficulties. For further insights on this market. request a sample here

North America was the largest region in the tardive dyskinesia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tardive dyskinesia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us